Mini-Focus Issue: Prognostic Measures in Heart FailureImpact of Degree of Left Ventricular Remodeling on Clinical Outcomes From Cardiac Resynchronization Therapy
Graphical abstract
Key Words
Abbreviations and Acronyms
Cited by (0)
Supported by Boston Scientific and by the Statistical Data Analysis Center, University of Wisconsin, Madison, Wisconsin. Analysis of data was supported by Statistical Data Analysis Center, University of Wisconsin. Dr. De Marco has received consulting fees from Boston Scientific; and is a speaker for Novartis. Dr. Lindenfield has consultant relationships with Abbott Lab, Edwards Life Science, Novartis, Boston Scientific, VWave, Relypsa, ResMed, CVRX, and Cardiotronix. Dr. Saxon is Executive Director, University of Southern California Center for Body Computing; and has received fees for consulting for Abbott Lab. Dr. Boehmer has received fees for consulting from Boston Scientific and Medtronic; and has received research support from Boston Scientific and Abbott Lab. Ms. Leigh is an employee of Boston Scientific. Mr. Yong is an employee of Boston Scientific. Dr. Bristow is a compensated Director of ARCA biopharma; and holds equity in ARCA biopharma. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Barry Greenberg, MD, served as Guest Editor for this article.